1st Quarter - Report
SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.) for SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.)
Income
—
Expenses
$400,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Discussions regarding patent reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| ANTHONY MAGNETTI | — |
Medicare/Medicaid MMM
Issues regarding Medicare Part D, Medicare reimbursement issues Discussions regarding Medicare Part B
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| ANTHONY MAGNETTI | — |
Health Issues HCR
Discussions related to the IPAB Issues regarding general health care reform (no specific bill#) Essential Health Benefits Discussions regarding Perscription Drug User Fee Act (PDUFA) Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| ANTHONY MAGNETTI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.